These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27843742)

  • 1. Recombinant human adenovirus-p53 therapy for the treatment of nasopharyngeal carcinoma: a meta-analysis.
    Yuan C; Xu XH; Chen Z
    Springerplus; 2016; 5(1):1885. PubMed ID: 27843742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined chemoradiation vs radiation therapy alone in stage-II nasopharyngeal carcinoma: A meta-analysis of the published literature.
    Wang S; Li S; Shen L
    Curr Probl Cancer; 2018; 42(3):302-318. PubMed ID: 29759802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Human Adenovirus-p53 Therapy for the Treatment of Cervical Cancer: A Meta-Analysis.
    Guo Y; Chen J; Zhang X; Fang M; Xu M; Zhang L; Rao E; Xin Y
    Front Oncol; 2021; 11():748681. PubMed ID: 34733786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of recombinant human adenovirus p53 combined with chemoradiotherapy in the treatment of recurrent nasopharyngeal carcinoma.
    Ma WS; Ma JG; Xing LN
    Anticancer Drugs; 2017 Feb; 28(2):230-236. PubMed ID: 27775992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human adenovirus p53 combined with transcatheter arterial chemoembolization for liver cancer: A meta-analysis.
    Guo Y; Chen Y; Zhang Y; Xu M; Guo W; Zhang J; Ma G; Liu C; Yang J; Wu X
    PLoS One; 2023; 18(12):e0295323. PubMed ID: 38127912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma.
    Pan JJ; Zhang SW; Chen CB; Xiao SW; Sun Y; Liu CQ; Su X; Li DM; Xu G; Xu B; Lu YY
    J Clin Oncol; 2009 Feb; 27(5):799-804. PubMed ID: 19103729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of S-1 Combined with Radiotherapy in the Treatment of Nasopharyngeal Cancer: A Meta-analysis Based on Randomized Controlled Trials.
    Fengtong J; Jiangtao F; Yating W; Lili W; Jianbo C; Xiaofei W
    Open Med (Wars); 2017; 12():107-114. PubMed ID: 28730169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoradiotherapy Versus Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: A Systemic Review and Meta-analysis of 2138 Patients.
    Xu C; Zhang LH; Chen YP; Liu X; Zhou GQ; Lin AH; Sun Y; Ma J
    J Cancer; 2017; 8(2):287-297. PubMed ID: 28243333
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant chemoradiotherapy versus radiotherapy alone in high-risk endometrial cancer: A systematic review and meta-analysis.
    Yi L; Zhang H; Zou J; Luo P; Zhang J
    Gynecol Oncol; 2018 Jun; 149(3):612-619. PubMed ID: 29530332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Significance of Radiotherapy in Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Zhuang Y; Yang H
    Cancer Control; 2023; 30():10732748231179291. PubMed ID: 37236911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis.
    Zhang B; Mo Z; Du W; Wang Y; Liu L; Wei Y
    Oral Oncol; 2015 Nov; 51(11):1041-1046. PubMed ID: 26296274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination treatment with antiEGFR monoclonal antibodies in advanced nasopharyngeal carcinoma : a meta-analysis.
    Yuan C; Xu XH; Chen Z
    J BUON; 2015; 20(6):1510-7. PubMed ID: 26854448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis.
    You R; Cao YS; Huang PY; Chen L; Yang Q; Liu YP; Zou X; Zhang YN; Jiang R; Zhang MX; Duan CY; Lin AH; Hong MH; Chen MY
    Theranostics; 2017; 7(19):4825-4835. PubMed ID: 29187906
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant adenovirus-p53 enhances the therapeutic effect of surgery and chemoradiotherapy combination in hypopharyngeal squamous cell carcinomas patients.
    Liu J; Lv D; Wang H; Zou J; Chen F; Yang H
    Medicine (Baltimore); 2018 Aug; 97(35):e12193. PubMed ID: 30170471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data.
    Fiorica F; Cartei F; Licata A; Enea M; Ursino S; Colosimo C; Cammà C
    Cancer Treat Rev; 2010 Nov; 36(7):539-49. PubMed ID: 20334979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cetuximab or Nimotuzumab Versus Cisplatin Concurrent with Radiotherapy for Local-Regionally Advanced Nasopharyngeal Carcinoma: a Meta-analysis.
    Liang ZG; Lin GX; Ye JX; Li Y; Li L; Qu S; Liang X; Zhu XD
    Asian Pac J Cancer Prev; 2018 May; 19(5):1397-1404. PubMed ID: 29802706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual patient data network meta-analysis using either restricted mean survival time difference or hazard ratios: is there a difference? A case study on locoregionally advanced nasopharyngeal carcinomas.
    Petit C; Blanchard P; Pignon JP; Lueza B
    Syst Rev; 2019 Apr; 8(1):96. PubMed ID: 30987679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Recombinant Human p53 Adenovirus Injection Combined with Radiotherapy or Concurrent Chemoradiotherapy in the Treatment of Cervical Cancer: A Systematic Review and Meta-analysis.
    Zhang G; Su G
    Altern Ther Health Med; 2024 Sep; 30(9):78-84. PubMed ID: 38639607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial.
    Yang Q; Cao SM; Guo L; Hua YJ; Huang PY; Zhang XL; Lin M; You R; Zou X; Liu YP; Xie YL; Wang ZQ; Mai HQ; Chen QY; Tang LQ; Mo HY; Cao KJ; Qian CN; Zhao C; Xiang YQ; Zhang XP; Lin ZX; Li WX; Liu Q; Li JB; Ling L; Guo X; Hong MH; Chen MY
    Eur J Cancer; 2019 Sep; 119():87-96. PubMed ID: 31425966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of residual or recurrent nasopharyngeal carcinoma treated with endoscopic nasopharyngectomy plus chemoradiotherapy or with chemoradiotherapy alone: a retrospective study.
    Weng J; Wei J; Si J; Qin Y; Li M; Liu F; Si Y; Su J
    PeerJ; 2017; 5():e3912. PubMed ID: 29038762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.